SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Gliatech (GLIA)
An SI Board Since November 1996
Posts SubjectMarks Bans Symbol
2001 20 0 GLIA
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1751who said I was referring to the press release?Ben Wa-8/30/2000
1750Jeffrey, I believe that you are missing the main point. GLIA had scar scores froDr. John M. de Castro-8/30/2000
1749John, I guess it depends on your perspective. This is what the company said, in jeffbas-8/30/2000
1748John, One afterthought I have worked on and off with the federal government forMark Bong-8/30/2000
1747GLIA, in its press release, has attempted to gloss over the seriousness of the FDr. John M. de Castro-8/30/2000
1746The FDA observations appear to be much more serious than simple interrater reliaDr. John M. de Castro-8/30/2000
1745Here are some clarifications of merger related problems from the Cleveland PlainDr. John M. de Castro-8/30/2000
1744Well, it sounds to me that the FDA has found a certain degree of sloppyness withSpekulatius-8/30/2000
1743Thanks for your erudite response, Ben. Unfortunately, your subtlety is beyond John Metcalf-8/30/2000
1742ummmm...this stock really sucks. he heh......he hehBen Wa-8/30/2000
1741Thanks for the note about schizophrenia in the Yahoo! link. {EDIT -- oops! No John Metcalf-8/30/2000
1740Guess that's the glycine transporter program. Never mind. (eom)scaram(o)uche-8/30/2000
1739<i>Gliatech's neurological disorders programs are focused on developmescaram(o)uche-8/29/2000
1738<<Second, GLIA has surely lost personnel. Since, the merger was announced,tommysdad-8/29/2000
1737re the bldg. development fees settlement, I'm almost certain there was an ouBill Tomko-8/29/2000
1736GLIA is a mess. The situation now is different from the FDA import ban. The compDr. John M. de Castro-8/29/2000
1735Genzyme is my "logical" choice for a suitor. Adcon goes to GZSP and thjeffbas-8/29/2000
1734Jeff, A fine assessment of GLIA I'd like to remind the faithful we all agreRWReeves-8/29/2000
1733The answer I was given re non disclosure was advise of consul and need to negoiaBill Tomko-8/29/2000
1732Peter, it seems to me there are two questions. Does the product do what it is sujeffbas-8/29/2000
1731The bull case here is that this FDA issue will drag on for several months beforeBiomaven-8/29/2000
1730The statement that I find the most revealing, it the one from the GLFD spokesperDr. John M. de Castro-8/29/2000
1729Adhesion Barriers opalapril, CHAI does have an ugly balance sheet..... No argubrad greene-8/29/2000
1728Mark, GLFD shouldn't get any kudos. The FDA issued the report on Aug. 23. ThDr. John M. de Castro-8/29/2000
1727Life Medical Bear, Check it out. CV trials, OBGYN trials, GS trials. lifemed.brad greene-8/29/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News